1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Gilquin, B.
Roumestand, C.
Zinn-Justin, S.
Menez, A.
Toma, F.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Biopolymers
BIPMAA
0161
0006-3525
33
1659
1675
10.1002/bip.360331104
8241426
Refined three-dimensional solution structure of a snake cardiotoxin: analysis of the side-chain organization suggests the existence of a possible phospholipid binding site.
1993
To be Published
0353
Proton NMR Studies of the Structural and Dynamical Effects of Chemical Modification of Single Aromatic Side Chain in a Snake Cardiotoxin
10.2210/pdb1cxo/pdb
pdb_00001cxo
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
6838.462
CARDIOTOXIN GAMMA
1
man
polymer
no
no
LKCNQLIPPFWKTCPKGKNLCYKMTMRAAPMVPVKRGCIDVCPKSSLLIKYMCCNTDKCN
LKCNQLIPPFWKTCPKGKNLCYKMTMRAAPMVPVKRGCIDVCPKSSLLIKYMCCNTDKCN
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
spitting cobra
Naja
sample
8654
Naja nigricollis
database_2
pdbx_database_status
pdbx_struct_assembly
pdbx_struct_oper_list
repository
Initial release
Version format compliance
Version format compliance
Database references
Derived calculations
Other
1
0
1994-12-20
1
1
2008-03-24
1
2
2011-07-13
1
3
2022-02-16
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.process_site
Y
BNL
1994-11-07
REL
9
BRUNGER
refinement
X-PLOR
LEU
1
n
1
LEU
1
A
LYS
2
n
2
LYS
2
A
CYS
3
n
3
CYS
3
A
ASN
4
n
4
ASN
4
A
GLN
5
n
5
GLN
5
A
LEU
6
n
6
LEU
6
A
ILE
7
n
7
ILE
7
A
PRO
8
n
8
PRO
8
A
PRO
9
n
9
PRO
9
A
PHE
10
n
10
PHE
10
A
TRP
11
n
11
TRP
11
A
LYS
12
n
12
LYS
12
A
THR
13
n
13
THR
13
A
CYS
14
n
14
CYS
14
A
PRO
15
n
15
PRO
15
A
LYS
16
n
16
LYS
16
A
GLY
17
n
17
GLY
17
A
LYS
18
n
18
LYS
18
A
ASN
19
n
19
ASN
19
A
LEU
20
n
20
LEU
20
A
CYS
21
n
21
CYS
21
A
TYR
22
n
22
TYR
22
A
LYS
23
n
23
LYS
23
A
MET
24
n
24
MET
24
A
THR
25
n
25
THR
25
A
MET
26
n
26
MET
26
A
ARG
27
n
27
ARG
27
A
ALA
28
n
28
ALA
28
A
ALA
29
n
29
ALA
29
A
PRO
30
n
30
PRO
30
A
MET
31
n
31
MET
31
A
VAL
32
n
32
VAL
32
A
PRO
33
n
33
PRO
33
A
VAL
34
n
34
VAL
34
A
LYS
35
n
35
LYS
35
A
ARG
36
n
36
ARG
36
A
GLY
37
n
37
GLY
37
A
CYS
38
n
38
CYS
38
A
ILE
39
n
39
ILE
39
A
ASP
40
n
40
ASP
40
A
VAL
41
n
41
VAL
41
A
CYS
42
n
42
CYS
42
A
PRO
43
n
43
PRO
43
A
LYS
44
n
44
LYS
44
A
SER
45
n
45
SER
45
A
SER
46
n
46
SER
46
A
LEU
47
n
47
LEU
47
A
LEU
48
n
48
LEU
48
A
ILE
49
n
49
ILE
49
A
LYS
50
n
50
LYS
50
A
TYR
51
n
51
TYR
51
A
MET
52
n
52
MET
52
A
CYS
53
n
53
CYS
53
A
CYS
54
n
54
CYS
54
A
ASN
55
n
55
ASN
55
A
THR
56
n
56
THR
56
A
ASP
57
n
57
ASP
57
A
LYS
58
n
58
LYS
58
A
CYS
59
n
59
CYS
59
A
ASN
60
n
60
ASN
60
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
CYS
3
A
N
CYS
3
A
O
LYS
12
A
O
LYS
12
A
O
ILE
39
A
O
ILE
39
A
N
LEU
20
A
N
LEU
20
A
N
THR
25
A
N
THR
25
A
O
LYS
50
A
O
LYS
50
1
-7.39
1.00
110.10
102.71
A
A
A
CG
CD1
NE1
TRP
TRP
TRP
11
11
11
N
1
8.08
0.90
109.00
117.08
A
A
A
CD1
NE1
CE2
TRP
TRP
TRP
11
11
11
N
1
9.22
1.10
130.40
139.62
A
A
A
NE1
CE2
CZ2
TRP
TRP
TRP
11
11
11
N
1
-6.28
1.00
107.30
101.02
A
A
A
NE1
CE2
CD2
TRP
TRP
TRP
11
11
11
N
2
-6.79
1.00
110.10
103.31
A
A
A
CG
CD1
NE1
TRP
TRP
TRP
11
11
11
N
2
7.88
0.90
109.00
116.88
A
A
A
CD1
NE1
CE2
TRP
TRP
TRP
11
11
11
N
2
10.03
1.10
130.40
140.43
A
A
A
NE1
CE2
CZ2
TRP
TRP
TRP
11
11
11
N
2
-6.67
1.00
107.30
100.63
A
A
A
NE1
CE2
CD2
TRP
TRP
TRP
11
11
11
N
3
-7.37
1.00
110.10
102.73
A
A
A
CG
CD1
NE1
TRP
TRP
TRP
11
11
11
N
3
8.20
0.90
109.00
117.20
A
A
A
CD1
NE1
CE2
TRP
TRP
TRP
11
11
11
N
3
9.77
1.10
130.40
140.17
A
A
A
NE1
CE2
CZ2
TRP
TRP
TRP
11
11
11
N
3
-6.62
1.00
107.30
100.68
A
A
A
NE1
CE2
CD2
TRP
TRP
TRP
11
11
11
N
3
26.76
2.70
111.00
137.76
A
A
A
N
CA
C
VAL
VAL
VAL
32
32
32
N
4
-7.55
1.00
110.10
102.55
A
A
A
CG
CD1
NE1
TRP
TRP
TRP
11
11
11
N
4
8.40
0.90
109.00
117.40
A
A
A
CD1
NE1
CE2
TRP
TRP
TRP
11
11
11
N
4
11.27
1.10
130.40
141.67
A
A
A
NE1
CE2
CZ2
TRP
TRP
TRP
11
11
11
N
4
-7.18
1.00
107.30
100.12
A
A
A
NE1
CE2
CD2
TRP
TRP
TRP
11
11
11
N
4
-5.75
0.90
133.90
128.15
A
A
A
CG
CD2
CE3
TRP
TRP
TRP
11
11
11
N
5
-7.45
1.00
110.10
102.65
A
A
A
CG
CD1
NE1
TRP
TRP
TRP
11
11
11
N
5
8.14
0.90
109.00
117.14
A
A
A
CD1
NE1
CE2
TRP
TRP
TRP
11
11
11
N
5
9.68
1.10
130.40
140.08
A
A
A
NE1
CE2
CZ2
TRP
TRP
TRP
11
11
11
N
5
-6.46
1.00
107.30
100.84
A
A
A
NE1
CE2
CD2
TRP
TRP
TRP
11
11
11
N
6
-7.33
1.00
110.10
102.77
A
A
A
CG
CD1
NE1
TRP
TRP
TRP
11
11
11
N
6
8.03
0.90
109.00
117.03
A
A
A
CD1
NE1
CE2
TRP
TRP
TRP
11
11
11
N
6
9.64
1.10
130.40
140.04
A
A
A
NE1
CE2
CZ2
TRP
TRP
TRP
11
11
11
N
6
-6.33
1.00
107.30
100.97
A
A
A
NE1
CE2
CD2
TRP
TRP
TRP
11
11
11
N
6
7.87
1.10
114.20
122.07
A
A
A
CA
CB
SG
CYS
CYS
CYS
54
54
54
N
6
6.84
1.10
114.20
121.04
A
A
A
CA
CB
SG
CYS
CYS
CYS
59
59
59
N
7
-6.87
1.00
110.10
103.23
A
A
A
CG
CD1
NE1
TRP
TRP
TRP
11
11
11
N
7
7.88
0.90
109.00
116.88
A
A
A
CD1
NE1
CE2
TRP
TRP
TRP
11
11
11
N
7
9.07
1.10
130.40
139.47
A
A
A
NE1
CE2
CZ2
TRP
TRP
TRP
11
11
11
N
7
-6.24
1.00
107.30
101.06
A
A
A
NE1
CE2
CD2
TRP
TRP
TRP
11
11
11
N
8
-6.31
1.00
110.10
103.79
A
A
A
CG
CD1
NE1
TRP
TRP
TRP
11
11
11
N
8
7.56
0.90
109.00
116.56
A
A
A
CD1
NE1
CE2
TRP
TRP
TRP
11
11
11
N
8
9.41
1.10
130.40
139.81
A
A
A
NE1
CE2
CZ2
TRP
TRP
TRP
11
11
11
N
8
-6.22
1.00
107.30
101.08
A
A
A
NE1
CE2
CD2
TRP
TRP
TRP
11
11
11
N
9
-6.87
1.00
110.10
103.23
A
A
A
CG
CD1
NE1
TRP
TRP
TRP
11
11
11
N
9
7.96
0.90
109.00
116.96
A
A
A
CD1
NE1
CE2
TRP
TRP
TRP
11
11
11
N
9
9.73
1.10
130.40
140.13
A
A
A
NE1
CE2
CZ2
TRP
TRP
TRP
11
11
11
N
9
-6.54
1.00
107.30
100.76
A
A
A
NE1
CE2
CD2
TRP
TRP
TRP
11
11
11
N
1
A
GLN
5
-103.86
-110.00
1
A
LEU
6
-66.56
-86.10
1
A
PRO
8
-65.28
-174.14
1
A
PHE
10
-24.37
76.58
1
A
LYS
18
-87.85
45.65
1
A
MET
31
-158.57
65.80
1
A
VAL
34
-138.27
-38.91
1
A
ARG
36
-173.52
145.31
1
A
PRO
43
-59.18
-178.37
1
A
LYS
58
70.55
-25.73
1
A
CYS
59
-54.57
1.23
2
A
GLN
5
-108.77
-101.43
2
A
LEU
6
-103.17
-95.72
2
A
ILE
7
-80.19
-77.47
2
A
LYS
18
-86.37
41.68
2
A
MET
31
-154.68
64.57
2
A
ILE
39
-124.67
-152.17
2
A
PRO
43
-51.35
173.50
2
A
SER
45
-55.99
97.37
2
A
CYS
54
-170.35
-177.05
2
A
LYS
58
65.63
-23.74
3
A
GLN
5
-98.14
-119.52
3
A
LEU
6
-52.29
-100.18
3
A
PRO
8
-45.49
-173.86
3
A
PHE
10
-3.51
69.82
3
A
PRO
30
-59.49
-85.48
3
A
PRO
33
-62.55
91.94
3
A
ARG
36
-175.52
135.56
3
A
ILE
39
-125.25
-157.42
3
A
PRO
43
-75.41
-165.15
3
A
LYS
44
-67.06
97.37
3
A
LYS
58
67.79
-24.23
4
A
CYS
3
-138.11
-147.17
4
A
LEU
6
-129.37
-56.32
4
A
ILE
7
-107.77
-145.09
4
A
PRO
8
-36.00
154.08
4
A
TRP
11
-156.00
-26.14
4
A
LYS
12
-55.02
172.02
4
A
LYS
18
-84.87
32.32
4
A
MET
31
-158.11
66.84
4
A
PRO
33
-65.13
98.50
4
A
ARG
36
-171.24
141.55
4
A
ILE
39
-118.18
-161.04
4
A
ASP
40
-142.62
-51.12
4
A
LYS
58
70.67
-24.15
5
A
GLN
5
-105.46
-124.45
5
A
LEU
6
-50.30
-101.53
5
A
ILE
7
-122.92
-51.81
5
A
PHE
10
174.99
74.57
5
A
ALA
29
-160.42
-153.73
5
A
VAL
32
-46.87
-160.47
5
A
PRO
33
-49.00
100.28
5
A
VAL
34
-143.48
-29.58
5
A
PRO
43
-75.29
-165.30
5
A
CYS
54
-162.98
-163.70
5
A
LYS
58
69.20
-23.95
5
A
CYS
59
-54.89
-0.08
6
A
LEU
6
41.23
-145.37
6
A
ILE
7
-96.52
-84.45
6
A
LYS
18
-88.52
45.84
6
A
ASN
19
-87.78
40.05
6
A
ALA
29
-160.42
-37.29
6
A
PRO
33
-69.49
99.19
6
A
VAL
34
-93.98
-73.54
6
A
ILE
39
-132.37
-155.21
6
A
ASP
40
-121.25
-60.53
6
A
PRO
43
-55.85
172.78
6
A
CYS
54
-166.25
-163.50
6
A
ASN
55
-141.78
-32.89
6
A
LYS
58
69.86
-26.22
7
A
GLN
5
-137.16
-127.71
7
A
LEU
6
-84.76
-89.59
7
A
ILE
7
-79.21
-85.12
7
A
PRO
8
-49.40
174.81
7
A
LYS
16
-39.57
131.61
7
A
LYS
18
-91.18
44.58
7
A
ALA
29
-159.39
-154.02
7
A
VAL
32
-50.01
-154.87
7
A
PRO
33
-39.95
99.65
7
A
VAL
34
-146.22
-39.92
7
A
ILE
39
-125.95
-150.59
7
A
ASP
40
-125.03
-59.66
7
A
PRO
43
-55.19
176.93
7
A
SER
45
-70.00
97.50
7
A
CYS
54
-173.59
143.21
7
A
LYS
58
72.44
-26.43
8
A
GLN
5
-95.35
-127.18
8
A
LEU
6
-66.89
-126.20
8
A
PRO
8
-44.00
167.81
8
A
ASN
19
-84.40
32.56
8
A
LYS
23
-174.23
-146.53
8
A
ALA
29
-104.22
-158.06
8
A
PRO
30
-67.19
-79.50
8
A
MET
31
-155.66
64.65
8
A
PRO
33
-67.35
91.23
8
A
ARG
36
-160.55
107.46
8
A
ILE
39
-137.04
-155.29
8
A
ASP
40
-113.34
-70.17
8
A
CYS
42
-38.67
116.31
8
A
ASP
57
-46.72
151.89
8
A
LYS
58
66.51
-24.54
8
A
CYS
59
-57.06
-1.33
9
A
LEU
6
-146.17
-122.69
9
A
ILE
7
-91.64
-61.01
9
A
PRO
9
-51.49
6.13
9
A
LYS
16
-40.51
102.97
9
A
LYS
18
-125.14
-126.81
9
A
ASN
19
-148.61
36.61
9
A
PRO
30
-59.53
-70.19
9
A
MET
31
-157.31
66.97
9
A
VAL
34
-145.92
-49.81
9
A
ILE
39
-135.31
-152.23
9
A
ASP
40
-123.77
-63.64
9
A
PRO
43
-75.84
-167.68
9
A
LYS
58
65.00
-21.66
model building
X-PLOR
refinement
X-PLOR
phasing
X-PLOR
REFINED THREE-DIMENSIONAL SOLUTION STRUCTURE OF A SNAKE CARDIOTOXIN: ANALYSIS OF THE SIDE-CHAIN ORGANISATION SUGGESTS THE EXISTENCE OF A POSSIBLE PHOSPHOLIPID BINDING SITE
1
Y
N
disulf
2.019
A
CYS
3
A
SG
CYS
3
1_555
A
CYS
21
A
SG
CYS
21
1_555
disulf
2.020
A
CYS
14
A
SG
CYS
14
1_555
A
CYS
38
A
SG
CYS
38
1_555
disulf
2.016
A
CYS
42
A
SG
CYS
42
1_555
A
CYS
53
A
SG
CYS
53
1_555
disulf
2.018
A
CYS
54
A
SG
CYS
54
1_555
A
CYS
59
A
SG
CYS
59
1_555
CYTOTOXIN
CYTOTOXIN
CX1_NAJPA
UNP
1
1
P01468
LKCNQLIPPFWKTCPKGKNLCYKMTMRAAPMVPVKRGCIDVCPKSSLLIKYMCCNTDKCN
1
60
1CXO
1
60
P01468
A
1
1
60
2
3
anti-parallel
anti-parallel
anti-parallel
A
LYS
2
A
LYS
2
A
ASN
4
A
ASN
4
A
TRP
11
A
TRP
11
A
THR
13
A
THR
13
A
VAL
32
A
VAL
32
A
ILE
39
A
ILE
39
A
LEU
20
A
LEU
20
A
MET
26
A
MET
26
A
ILE
49
A
ILE
49
A
CYS
54
A
CYS
54
1
P 1